Blood Vessel Occlusion by the Layperson Audiovisual Assist Tourniquet (LAVA TQ) Compared to the Combat Application Tourniquet: Randomized Controlled Trial.

"Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. This study was funded by the Defense Health Agency’s Transforming Technology for the Warfighter grant [NM91959717] via the Uniformed Services University’s National Center for Disaster Medicine and Public Health. Drs. Goolsby and Kothera declare that they have a provisional patent pending for LAVA TQ."

"Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. This study was funded by the Defense Health Agency’s Transforming Technology for the Warfighter grant [NM91959717] via the Uniformed Services University’s National Center for Disaster Medicine and Public Health. Drs. Goolsby and Kothera declare that they have a provisional patent pending for LAVA TQ."

"This study was a prospective, blinded, randomized controlled trial to assess non-inferiority of the novel LAVA TQ (experimental arm) to occlude blood flow in human volunteers when compared to the CAT (control arm). The Uniformed Services University (USU) Institutional Review Board (IRB) reviewed and approved this study (USUHS.2020-060), and it is registered on the National Library of Medicine’s Clinical Trials website (clinicaltrials.gov, NCT05504733)."